Trials / Unknown
UnknownNCT02493231
Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Hallym University Kangnam Sacred Heart Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- —
Summary
Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam,which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nefopam | |
| DRUG | Ketamine | |
| DRUG | Saline |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-12-01
- First posted
- 2015-07-09
- Last updated
- 2015-09-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02493231. Inclusion in this directory is not an endorsement.